Reference News Network reported on November 25th that foreign media said that people with autoimmune diseases such as rheumatoid arthritis, lupus, autoimmune hepatitis, mammary diarrhea, multiple sclerosis or type I diabetes are always living in fear of the novel coronavirus pandemic. Many experts believe that the above situation has led to these patients becoming the most vulnerable to COVID-19.
According to the Economic News Network of Buenos Aires, Argentina, on November 24, this is firstly because these diseases themselves cause the body to attack itself, which damage important organs such as the lungs, kidneys, cardiovascular system, etc. Second, more importantly, most of these diseases are treated with immunosuppressive drugs. And it increases the risk of infection with the virus.
According to WHO data on the current situation of the epidemic, patients over 60 years old and accompanied by diseases have the highest mortality rate. The most common diseases are cardiovascular diseases, diabetes, chronic respiratory diseases, hypertension, kidney diseases, etc.
According to the report, in recent years, most of the viruses that cause epidemic are zoonositivity viruses, which come from different animal hosts. In terms of COVID-19, it is likely bats. Bats are the natural hosts of these viruses, and their immunity is enough to allow these viruses to stay in their bodies. These findings may be of reference significance in dealing with the infection status of patients with low immunity.
A new study has found the relationship between immune-mediated diseases and COVID-19. The researchers first observed that in those patients with systemic autoimmune diseases, the “incidence” of COVID-19 disease is higher, generally higher than that of the general population, except for systemic lupus erythematosus.
In this study, the researchers set the goal of the study to determine how rheumatism patients are threatened by COVID-19, as well as the probability of infection and symptom characteristics, and verify the possible impact of using immunosuppressive drugs in these cases.
Researchers warn that for patients with rheumatism caused by immune problems, their pathology is immune-based and they receive different immunosuppressive treatments, so they are at greater risk of infection.
In the study, they observed that these patients had a “higher incidence” of COVID-19. In addition, patients with chronic arthritis who receive bio-directed treatment also show a high incidence.
The report pointed out that the researchers focused on the threat of COVID-19 to immune-induced diseases. The risk factors for severe COVID-19 include over 60 years old, men and systemic autoimmune diseases.